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1. Introduction 
The regulation of carbon flux through the hepatic 
fructose bisphosphatase-phosphofructokinase sub- 
strate cycle is regulated, in part, by the level of a 
novel sugar phosphate fructose 2,6-P2 [ 1-7]. Methods 
for its synthesis and its anomeric specificity have been 
reported [8,9]. We also reported that the level of 
fructose 2,6-P2 could be regulated by a variety of 
hormones and agents (e.g., ct-agonists, vasopressin and 
the Ca2+ ionophore A23187) [ 10-12]. The existence 
of an enzyme, separate from phosphofructokinase, 
was described which could synthesize fructose 2,6-P2 
from fructose 6-P and Mg-ATP and the activity of the 
enzyme was inhibited following lucagon pretreatment 
of liver [11,13-15]. 
The role played by fructose 2,6-P2 in controlling 
flux through the non-oxidative s gment of the pentose 
pathway was thus investigated since altro heptulose 
7-P* and altro heptulose 1,7-P2 are also substrates for 
phosphofructokinase nd fructose bisphosphatase, 
respectively [16-18]. altro Heptulose 1,7-P2 is not 
considered to be an intermediate of the pentose phos- 
phate pathway as seen in current ext books, however 
recent studies have shown that it is present in liver 
tissue and can be formed by liver enzymes in vitro 
[19-21]. altro Heptulose 1,7-P2 does play a key role 
in the path of carbon in photosynthesis [22]. The 
absence of measurable levels oferythrose 4-P monomer 
may also be accounted for by the presence ofaltro 
heptulose 1,7-P2, since aldolase will condense ryth- 
rose 4-P and dihydroxyacetone-P to form this inter. 
mediate [23,24]. 
* altro heptulose is the systematic name for sedoheptulose 
Here, the effect of glucose and glucagon on the 
levels of the two heptulose phosphates is shown, since 
these agents will produce increased and decreased 
levels, respectively, of fructose 2,6-P2 [ 11 ]. Increased 
levels of fructose 2,6-P2 would theoretically increase 
the concentration faltro heptulose 1,7-P2, while 
decreased levels of fructose 2,6-P~, as in the case of 
glucagon treatment, would lower its concentration. 
These predictions were realized suggesting that flux 
of carbon through reactions of the pentose pathway 
can be regulated by the levels of fructose 2,6-P2. 
2. Experimental 
Livers from fed male Sprague Dawley rats (250 g 
body wt) were perfused by recirculation as in [25]. 
The perfusate contained either 10 -s M glucagon (Eli 
Lilly Co.), 50 mM glucose or no addition (control) 
and the perfusion continued for 15 min after which 
time the livers were freeze-clamped [26]. The sugar-P's 
were then isolated as their Ba 2÷ salts from 40 g (wet 
wt) tissue (pooled from separate liver perfusions) 
from each experimental condition [2]. Following 
removal of Ba 2+ [2] the samples were applied to a col- 
umn (28 X 1.8 cm) of Dowex 1 × 8 (200-400 mesh) 
ion-exchange r sin in the borate form (Bio-Rad Labs, 
Richmond CA). Sugar P's were eluted with a linear 
gradient of 0.1-0.4 M ammonium tetraborate (250 ml 
of each), 5 ml fractions were collected. The column 
was then eluted further with 0.4 M ammonium tetra- 
borate until all the sugar bisphosphates were removed. 
The heptulose P's were located and quantitated in the 
column profile by the cysteine-H2SO4 method [27]. 
The difference in absorbance at505 and 550 nm was 
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determined for each sample together with standards 
of altro heptulosan monohydrate [ 18]. 
3. Results 
The enzymatic methods currently used to measure 
altro heptulose 7-P and altro heptulose 1,7-P2 are not 
specific (see below) for each heptulose, hence the best 
approach to quantitate these heptuloses i to separate 
them by ion-exchange chromatography and quantitate 
them using the specific cysteine-H2S04 method [27]. 
The enzymatic method in [28] not only estimates 
altro heptulose 1,7-P2 but also D-glycero D-ido 
octulose 1,8-P2, D-glycero D-altro octulose 1,8-P2, 
fructose-l-P and fructose-1,6-P2 which are also present 
in liver [20]. The enzymatic method in [29] for altro 
heptulose 7-P will also detect D-glycero D-altro 
octulose 8-P which has been detected in liver [20]. 
The concentration of altro heptulose 7-P increases 
~50% and 400%, respectively, in livers perfused with 
50 mM glucose or 10 -8 M glucagon when compared 
to control ivers (fig.l). In the case of the 50 mM glu- 
cose perfusion, the small increase in altro heptulose 
7-P concentration presumably results from the 
increased hexose 6-P concentration which occurs in 
this condition [ 11 ] together with the following reac- 
tions. Reaction (1) being catalyzed by transketolase 
and transaldolase [30]: 
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Fig,1. Elution profile ofaltro heptulose 7-P from control, 
glucose and glucagon treated livers. For other details see sec- 
tion 2. Authentic altro heptulose 7-P (Sigma Chemical Co.) 
co-elutes with the heptulose from each of the conditions (not 
shown). 
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Fig.2. Elution profile of altro heptulose 1,7-P 2 from control, 
glucose and glucagon treated livers. For other details see sec- 
tion 2. The bisphosphate region of the profiles in fig.1 are 
shown. Authentic altro heptulose 1,7-P~ (Sigma Chemical 
Co.) co-elutes with the heptulose from each of the conditions 
(not shown). 
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2 Fructose 6-P -~altro heptulose 7-P + 
xylulose 5-P O) 
while reaction (2) is catalyzed by transketolase: 
Fructose 6-P + ribose 5-P ~ altro heptulose 7-P + 
erythrose 4-P (2) 
Also increased flux through reactions of the oxi- 
dative segment of the pentose pathway, together with 
the transketolase r action (reaction (3)) would con- 
tribute to the increased altro heptulose 7-P levels. 
phofructokinase, which would be inhibited in this 
condition due to the decreased level of fructose 2,6-P2 
[ 11 ]. Altematively it could arise from altro heptulose 
1,7-P2 by the activation of fructose bisphosphatase 
which occurs after glucagon treatment [5]. Consistent 
with this, the level ofaltro heptulose 1,7-P2 is decreased 
in the glucagon condition (fig.2). 
The concentration faltro heptulose 1,7-P2 is 
increased following glucose infusion (fig.2). This is 
consistent with fructose 2,6-P2 activating phospho- 
fructokinase which would convert altro heptulose 7-P 
to altro heptulose 1,7-P2. 
Ribose 5-P + xylulose 5-P ~ altro heptulose 7-P + 
glyceraldehyde 3-P (3) 4. Discussion 
In the glucagon treated liver, the increased altro 
heptulose 7-P concentration would be due to the 
same set of reactions as above, together with a 
decreased utilization ofaltro heptulose 7-P by phos- 
Although there appears to be some debate regarding 
the mechanism of the non-oxidative pentose phos- 
phate pathway in liver [31-34], there is very clear 
evidence for the existence in liver tissue of altro 
ribose 5-P 
glyceraldehyde 3-P 
dihydroxyacetone-P 
xylulose 5-P 
~Ka l t ro  heptulose 7-P 
FDPase P i PFK 
~ADP 
altro heptulose 1,7-P 2 
~ ALD 
erythrose 4-P 
glyceraldehyde 3-P 
xylulose 5-P 
~ T K  
fructose 6-P 
Sum: 3 Pentose 5-P + ATP ~ fructose 6-P + 3 tr iose P + ADP 
Fig.3. Alternate reaction sequence for the nonoxidative pentose pathway involving the enzymes FDPase and PFK. Abbreviations: 
FDPase, fructose 1,6-bisphosphatase; PFK, phosphofructokinase; TK, transketolase; ALD, aldolase. 
257 
Volume 142, number 2 FEBS LETTERS June 1982 
heptulose 1,7-P2 (here and [19,20]). Its concentration 
in control iver perfusions was ~10 nmol/g tissue 
(fig.2) which is similar to 5-7 nmol/g tissue found in 
[20]. This intermediate plays a r61e in the proposed 
L-type pentose pathway [35,36], and the existence of 
octulose phosphates [19,20] support he operation of 
this pathway. However, there does appear to be some 
doubt regarding the metabolic fate of arabinose 5-P 
another key intermediate in the L-type pentose path- 
way [33,34]. 
Another variant of the pentose phosphate pathway 
in liver is shown in fig.3 in which phosphofructoki- 
nase and fructose bisphosphatase play a r61e in the 
interconversion f altro heptulose 7-P and altro 
heptulose 1,7-P2. Since there are no convincing con- 
trol mechanisms demonstrated for controlling flux of 
carbon through the non-oxidative pentose pathway 
[37], the operation of the pathway shown in fig.3 
would serve to regulate the interconversion fhexose 
and pentose phosphates since phosphofructokinase 
and fructose bisphosphatase are under hormonal con- 
trol [1-7]. The labelling experiments performed in 
hepatocytes [36] are consistent with, but do not 
prove, the operation of the scheme in fig.3. 
These data support he notion that fructose 2,6-P2 
can regulate the levels ofaltro heptulose 7-P and altro 
heptulose 1,7-P2 in hepatocytes and that the pathway 
shown in fig.3 does operate in this tissue. Since no 
specific isotopic method is available to measure car- 
bon flux through reactions hown in fig.3, no quanti- 
tation of the pathway after glucagon and glucose 
treatment can be made. The changes in altro heptulose 
1,7-P2 and altro heptulose 7-P levels however are at 
present he only way of showing changes in flux 
through the pathway. Thus glucose and hormones 
(e.g., epinephrine and vasopressin) which increase the 
level of fructose 2,6-P2 [ 10,11 ] will stimulate flux 
through the pentose pathway shown in fig.3 in the 
direction of hexose phosphate, while agents which 
decrease its level (e.g., glucagon and/3-agonists) will 
decrease flux through the pathway. 
There appears to be a need to control the concen- 
tration of altro heptulose 7-P and altro heptulose 
1,7-P2 since altro heptulose 7-P is a competitive inhib- 
itor of phosphoglucose isomerase (K i = 9/aM) and 
erythrose 4-P (which arises by aldolase cleavage of 
altro heptulose 1,7-P2) is also a potent inhibitor of 
phosphoglucose isomerase (K i < 1/aM) [38]. Eryth- 
rose 4-P also inhibits transketolase, ribose phosphate 
isomerase and triose phosphate isomerase [24]. Thus 
control of phosphofructokinase nd fructose bisphos- 
phatase by fructose 2,6-P2 would regulate the levels 
of these inhibitors. 
On a final note, since the interconversion f fruc- 
tose 6-P and fructose 1,6-P2 is similar to that of altro 
heptulose 7-P and altro heptulose 1,7-P2 by the 
enzymes phosphofructokinase nd fructose bisphos- 
phatase one might speculate that by analogy the 
enzyme which synthesizes fructose 2,6-P2 from fruc- 
tose 6-P will also convert altro heptulose 7-P to altro 
heptulose 2,7-P2 and that this sugar phosphate, if 
formed, may also regulate phosphofructokinase nd 
fructose bisphosphatase. This intriguing possibility is 
under investigation. 
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